Palantir's current valuation requires near-flawless execution and sustained hypergrowth, leaving little margin for error. See why PLTR stock is a Hold.
Microsoft stock has ambitious earnings expectations. Explore the tech giant's outlook, real EPS growth potential, and investment risks.
Artificial intelligence has taken many forms over the years and is still evolving. Will machines soon surpass human knowledge and understanding?
Churn at Tesla and xAI comes amid disillusionment with billionaire’s activism, strategic pivots and mass lay-offs ...
Centralized exchanges (CEXs) were the foundation of the crypto economy, enabling retail investors and institutions to trade Bitcoin, Ethereum, and an ...
Guinea sets presidential election for Dec. 28, 2025 • New constitution allows junta members, including Doumbouya, to run • Key parties suspended amid vote buildup, tensions remain high Guinea has ...
Qigong, a type of mind-body exercise, has been adopted by some patients with cancer to improve their QoL. However, various lengthy questionnaires were used to assess Qigong’s effects which made data ...
Jash Engineering Limited has announced the completion of 52 years of operations and the launch of its quarterly newsletter. The newsletter aims to keep customers, suppliers, and stakeholders informed ...
It’s Midnight alpha Eve (well almost), with the invite-only alpha build going live imminently with an announced set of content phases, and the public beta is probably starting about 6 weeks later. As ...
Premier Energies Limited has secured contracts worth USD 19.95 million for the supply and installation of solar power systems in the Republic of Benin, West Africa. The contracts include the ...
A first-in-class LRP1 agonist, SP16 phase 1b Chemotherapy Induced Neuropathy (CIPN) Study fully funded by the National Cancer Institute, with ...
ATLANTA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a clinical-stage biotechnology company developing new medicines to treat pain and ...